Document Type

Article

Publication Date

2020

Abstract

The modified Friedreich Ataxia Rating Scale (mFARS) is a disease specific, exam-based neurological rating scale commonly used as a outcome measure in clinical trials. While extensive clinimetric testing indicates it’s validity in measuring disease progression, formal test–retest reliability was lacking. To fill this gap, we acquired results from screening and baseline visits of several large clinical trials and calculated intraclass correlation coefficients, coefficients of variance, standard error, and the minimally detectable changes. This study demonstrated excellent test–retest reliability of the mFARS, and it’s upright stability subscore.

Digital Object Identifier (DOI)

https://doi.org/10.1002/acn3.51118

Rights Information

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Citation / Publisher Attribution

Animals of Clinical and Translational Neurology, v. 7, issue 9, p. 1708-1712

Was this content written or created while at USF?

Yes

Included in

Neurology Commons

Share

COinS